We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$487M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$48.2M
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$29.4M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$28.9M
5
MSFT icon
Microsoft
MSFT
+$27.7M

Top Sells

Rank Stock Value
1
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$51.8M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$38.5M
3
SOXL icon
Direxion Daily Semiconductor Bull 3X ETF
SOXL
+$32.6M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$21M
5
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$16.6M

Sector Composition

Rank Sector Weight
1 Technology 6.25%
2 Industrials 4.6%
3 Consumer Discretionary 4.31%
4 Healthcare 4.26%
5 Financials 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WFH
2626
DELISTED
Direxion Work From Home ETF
WFH
$190K ﹤0.01%
+3,525
New +$189K
EWY icon
2627
iShares MSCI South Korea ETF
EWY
$27.6B
$189K ﹤0.01%
2,894
-1,885
-39% -$118K
GNSS icon
2628
Genasys
GNSS
$77.4M
$189K ﹤0.01%
30,666
-17,944
-37% -$85.5K
KALV
2629
DELISTED
KalVista Pharmaceuticals
KALV
$188K ﹤0.01%
14,971
+1,312
+10% +$16.4K
HTLF
2630
DELISTED
Heartland Financial USA, Inc.
HTLF
$188K ﹤0.01%
6,269
+2,172
+53% +$69.7K
ITI
2631
DELISTED
Iteris, Inc.
ITI
$188K ﹤0.01%
45,734
+36,519
+396% +$169K
SMMF
2632
DELISTED
Summit Financial Group, Inc.
SMMF
$188K ﹤0.01%
12,713
+10,132
+393% +$157K
PCSB
2633
DELISTED
PCSB Financial Corporation
PCSB
$188K ﹤0.01%
15,560
+12,951
+496% +$159K
KIN
2634
DELISTED
Kindred Biosciences, Inc.
KIN
$188K ﹤0.01%
43,637
+35,429
+432% +$148K
PCYO icon
2635
Pure Cycle
PCYO
$273M
$187K ﹤0.01%
20,718
+14,748
+247% +$139K
GTM
2636
ZoomInfo Technologies
GTM
$1.25B
$187K ﹤0.01%
+4,354
New +$171K
MCBC
2637
DELISTED
Macatawa Bank Corp
MCBC
$187K ﹤0.01%
28,611
+23,412
+450% +$169K
CLR
2638
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$187K ﹤0.01%
15,195
+13,521
+808% +$220K
CNBKA
2639
DELISTED
Century Bancorp Inc/Mass
CNBKA
$187K ﹤0.01%
2,851
+2,211
+345% +$157K
BYSI icon
2640
BeyondSpring
BYSI
$41M
$186K ﹤0.01%
13,991
+11,674
+504% +$152K
IBKR icon
2641
Interactive Brokers
IBKR
$41.4B
$186K ﹤0.01%
15,380
-14,052
-48% -$175K
IPI icon
2642
Intrepid Potash
IPI
$490M
$186K ﹤0.01%
22,012
+18,727
+570% +$178K
IVZ icon
2643
Invesco
IVZ
$13.9B
$186K ﹤0.01%
16,364
+9,504
+139% +$101K
ORI icon
2644
Old Republic International
ORI
$10.3B
$186K ﹤0.01%
12,647
-17,905
-59% -$286K
PLYM
2645
DELISTED
Plymouth Industrial REIT
PLYM
$186K ﹤0.01%
15,080
+13,717
+1,006% +$179K
NAGE
2646
Niagen Bioscience
NAGE
$242M
$186K ﹤0.01%
46,434
+36,743
+379% +$177K
AKR icon
2647
Acadia Realty Trust
AKR
$2.84B
$185K ﹤0.01%
17,675
+10,503
+146% +$126K
RFL icon
2648
Rafael Holdings
RFL
$103M
$185K ﹤0.01%
12,138
+9,117
+302% +$142K
STRO icon
2649
Sutro Biopharma
STRO
$353M
$185K ﹤0.01%
1,842
+1,154
+168% +$109K
TLYS icon
2650
Tilly's
TLYS
$121M
$185K ﹤0.01%
30,561
+23,492
+332% +$148K
104 105
106
107 108

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.